[Therapy of chronic hepatitis C].

Abstract excerpt

Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current and evolving therapies for chronic hepatitis C. Standard therapy with pegylated interferon-alpha and ribavirin achieves sustained virologic response rates of up to 40-50% in genotype 1- and about 80% in genotype 2- and 3-infected patients....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Administration Schedule
• Share to Drug Therapy, Combination
• Share to Hepacivirus